Medical Manager, Solid Tumor, Malaysia
BeOne Medicines
About this role
The Medical Manager, Solid Tumor at BeOne is responsible for the local medical execution of tislelizumab in Malaysia, supporting scientific exchange, medical education, and evidence generation. The role involves working closely with the Medical Director to translate medical strategy into high-quality, compliant execution focused on solid tumor indications such as NPC and NSCLC.
Skills
About BeOne Medicines
beonemedicines.comBeOne Medicines, formerly BeiGene, is committed to developing innovative cancer medicines by partnering globally to serve patients everywhere.
Recent company news
Simply Wall StBeOne Medicines Pharma Alliances Contrast With High P/E And Valuation Upside
5 hours ago
Stock TitanONC SEC Filings - BeOne Medicines Ltd. 10-K, 10-Q, 8-K Forms
11 hours ago
MarketBeatJPMorgan Chase & Co. Has $16.63 Million Stock Position in BeOne Medicines Ltd. - Sponsored ADR $ONC
11 hours ago
FinvizBeOne Medicines (ONC) Reports $1.5B Revenue for Q4, $1.1B from Lymphoma Treatment
3 days ago
TradingViewBeOne Medicines Ltd. SEC 10-K Report
6 days ago
About BeOne Medicines
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Leadership Team
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
Unlock Company Insights
View leadership team, funding history,
and employee contacts for BeOne Medicines.
Salary
$60k – $90k
per year
More jobs at BeOne Medicines
Similar Jobs
Medical Director, Clinical Development, Solid Tumor Oncology
Regeneron Pharmaceuticals
Regional Director Field Medical Solid Tumors - Tumor Point North East
0468 BMS Polska Sp. z o.o.
Medical Science Liaison (MSL)/Sr. MSL - Texas
Genmab
Medical Science Liaison (MSL)/Sr. MSL - Central
Genmab
Medical Science Liaison (MSL)/Sr. MSL - Mid-Atlantic
Genmab
Regional Director Field Medical Solid Tumors - Tumor Point Central
0468 BMS Polska Sp. z o.o.